Phylos Bioscience, Inc. - fund raising filing

Filings

Date	FilingType	Reported Sold	Incremental Cash	Type	Exemptions	Link to Raw Filing
2025-01-23	Amended	$4,518,519	$0	Equity Only	06b	SEC link
2024-11-01	New	$1,805,037	$1,805,037	Equity Only	06b	SEC link
2024-01-24	Amended	$4,518,519	$0	Equity Only	06b	SEC link
2023-11-07	New	$150,000	$150,000	Equity and Debt	06b	SEC link
2023-02-17	New	$250,000	$250,000	Equity and Debt	06b	SEC link
2023-01-26	Amended	$4,518,519	$4,518,519	Equity Only	06b	SEC link
2022-01-24	Amended	$0	$0	Equity Only	06b	SEC link
2021-12-10	New	Yet to Sell	$0	Equity Only	06b	SEC link
2021-05-05	New	$2,500,000	Unknown	Equity and Debt		SEC link
2021-04-19	Amended	$12,158,792	$0	Equity Only	06c	SEC link
2021-01-27	Amended	$4,518,519	$0	Equity and Debt	06b	SEC link
2020-05-05	Amended	$12,158,792	$10,158,792	Equity Only	06c	SEC link
2020-01-30	New	Yet to Sell	$0	Equity and Debt	06b	SEC link
2019-05-10	Amended	$2,000,000	$2,000,000	Equity Only	06c	SEC link
2019-01-03	New	Yet to Sell	$0	Equity Only	06b	SEC link
2017-12-26	New	$250,000	$250,000	Equity and Debt	06b	SEC link
2016-09-16	Amended	$1,430,000	$1,180,000	Equity and Debt	06b	SEC link
2015-09-18	Amended	$250,000	$0	Equity and Debt	06b	SEC link
2015-09-17	New	$250,000	$250,000	Equity and Debt	06b	SEC link
2015-02-03	New	$250,000	$250,000	Equity Only	06b	SEC link

Directors and Executives (Current and Past)

Name	Role
Dylan Anderson	Executive
Scott Bowman	Executive
Timothy J Gregory	Director
Mowgli Holmes	Director, Executive
Nishan Karassik	Director, Executive
Stephen Lile	Executive
Mina Mishrikey	Director
David Patterson	Director
Barbara Peachey	Executive
Lada Rasochova, Ph D	Director
Dan Reiner	Director
Ralph J Risch	Director, Executive